Scotts Miracle-gro CO Form 4 insider transactions

NYSE
Roberto Candelino, a Director at The Scotts Miracle-Gro Company (SMG), acquired 34 dividend equivalent rights, increasing his beneficial ownership to 72 such rights.
NYSE
David C. Evans, a Director at Scotts Miracle-Gro Co. (SMG), acquired 97 dividend equivalent rights on June 6, 2025, increasing his beneficial ownership of such rights to 558.
NYSE
Scotts Miracle-Gro Company Director Stephen L. Johnson has reported the acquisition of 122 dividend equivalent rights, aligning his interests with shareholders.
NYSE
Scotts Miracle-Gro Company Director Edith Aviles has reported the acquisition of 97 dividend equivalent rights, increasing her beneficial ownership of derivative securities.
NYSE
A recent SEC Form 4 filing indicates that Nick Miaritis, a Director at The Scotts Miracle-Gro Company, acquired 30 additional Dividend Equivalent Rights, aligning his interests further with shareholders.
NYSE
Scotts Miracle-Gro Chairman and CEO James Hagedorn acquired 2,109.81 shares of phantom stock on June 6, 2025, increasing his total beneficial ownership to 217,849.189 shares.
NYSE
Scotts Miracle-Gro's EVP, CFO & CAO, Mark J. Scheiwer, reported the acquisition of dividend equivalent rights and phantom stock as part of his compensation on June 6, 2025.
NYSE
Brian E. Sandoval, a Director at The Scotts Miracle-Gro Company, acquired 141 dividend equivalent rights, valued at $66.48 each, on June 6, 2025, increasing his beneficial ownership to 809 derivative securities.
NYSE
Scotts Miracle-Gro Company Director Mark D. Kingdon has reported the acquisition of 85 dividend equivalent rights, valued at $66.48 per right, as part of a routine transaction.
NYSE
James Hagedorn, Chairman and CEO of Scotts Miracle-Gro Co, acquired 1,484.354 shares of phantom stock on May 27, 2025, increasing his total beneficial ownership to 215,739.379 shares.
NYSE
Mark J. Scheiwer, Executive Vice President, Chief Financial Officer, and Chief Administrative Officer of The Scotts Miracle-Gro Company, acquired 9.346 shares of phantom stock on May 27, 2025.
NYSE
Christopher Hagedorn, EVP & Chief of Staff at Scotts Miracle-Gro, reports acquiring common shares on April 25, 2025.
NYSE
Nathan Baxter, President and COO of Scotts Miracle-Gro, reported the acquisition and disposal of common shares, resulting in adjustments to his direct and indirect beneficial ownership.
NYSE
James Hagedorn, Chairman & CEO of Scotts Miracle-Gro, reports a transaction involving common shares on April 25, 2025.
NYSE
Mark J. Scheiwer, EVP, CFO & CAO of Scotts Miracle-Gro, reports acquiring common shares through a transaction on April 25, 2025.
NYSE
Hagedorn Partnership, a 10% owner and related to directors of Scotts Miracle-Gro Co, sold 25,000 common shares at an average price of $52.87 on May 2, 2025.
NYSE
Mark J. Scheiwer, EVP, CFO & CAO of Scotts Miracle-Gro, acquired 11,436 stock options on May 1, 2025.
NYSE
Mark J. Scheiwer, Interim CFO & CAO of Scotts Miracle-Gro, reports acquisition of phantom stock representing the right to receive common shares or their cash value.
NYSE
James Hagedorn, Chairman & CEO of Scotts Miracle-Gro, reports acquiring phantom stock representing the right to receive common shares or their cash value.
NYSE
Nathan Baxter, President and COO of Scotts Miracle-Gro, reports a transaction involving common shares, resulting in adjustments to his direct and indirect beneficial ownership.
NYSE
Christopher Hagedorn, EVP & Chief of Staff at Scotts Miracle-Gro, reports acquiring additional common shares in a recent transaction.
NYSE
Nathan Eric Baxter, President and COO of Scotts Miracle-Gro, reports the acquisition of common shares and updates beneficial ownership.
NYSE
Mark J. Scheiwer, Interim CFO & CAO of Scotts Miracle-Gro, reports acquisition of common shares and holdings in 401(K) plan.
NYSE
James Hagedorn, Chairman & CEO of Scotts Miracle-Gro, reports acquiring additional common shares through a transaction on March 25, 2025.
NYSE
James Hagedorn, Chairman & CEO of Scotts Miracle-Gro, settled phantom stock units for common shares and reported changes in beneficial ownership on April 3, 2025.
NYSE
Director Stephen L. Johnson acquired 263 common shares of Scotts Miracle-Gro Co. through deferred stock units on April 1, 2025.
NYSE
Director Brian E. Sandoval acquired 525 common shares of Scotts Miracle-Gro Co. on April 1, 2025, at a price of $54.77 per share.
NYSE
James Hagedorn, Chairman & CEO of Scotts Miracle-Gro, reports acquiring phantom stock representing the right to receive common shares or their cash value.
NYSE
Mark J. Scheiwer, Interim CFO & CAO of Scotts Miracle-Gro, reports acquisition of phantom stock convertible to common shares.
NYSE
Director Roberto Candelino reports acquisition of dividend equivalent rights convertible to 35 common shares of Scotts Miracle-Gro Co.